GREM1 and metabolic dysfunction-associated steatohepatitis: They detected increased transcription of gremlin mRNA in individuals with T2DM, glucose intolerance, non-alcoholic steatohepatitis (NASH), and non-alcoholic fatty liver disease (NAFLD) [104].